Page last updated: 2024-10-15

dinitrochlorobenzene and HIV Coinfection

dinitrochlorobenzene has been researched along with HIV Coinfection in 9 studies

Dinitrochlorobenzene: A skin irritant that may cause dermatitis of both primary and allergic types. Contact sensitization with DNCB has been used as a measure of cellular immunity. DNCB is also used as a reagent for the detection and determination of pyridine compounds.
1-chloro-2,4-dinitrobenzene : A C-nitro compound that is chlorobenzene carrying a nitro substituent at each of the 2- and 4-positions.

Research Excerpts

ExcerptRelevanceReference
" In this report, we describe an HIV-infected man with persistent, severe cutaneous hand warts that did not respond to multiple therapies, including liquid nitrogen cryotherapy, topical dinitrochlorobenzene, topical podophyllin, and intralesional interferon-alfa injections."3.70Resolution of recalcitrant hand warts in an HIV-infected patient treated with potent antiretroviral therapy. ( Colven, R; Spach, DH, 1999)
"Dinitrochlorobenzene (DNCB) is an inexpensive contact sensitizing agent that stimulates cell-mediated immunity when applied to the skin."2.68Topical immune modulation with dinitrochlorobenzene in HIV disease: a controlled trial from Brazil. ( Margulis, SB; Stricker, RB; Traub, A, 1997)
"In contrast, AIDS developed in 5 of the 11 noncompliant patients and four of these patients died."1.29Clinical and immunologic evaluation of HIV-infected patients treated with dinitrochlorobenzene. ( Dumlao, C; Elswood, BF; Epstein, WL; Goldberg, B; Henry, J; Stricker, RB; Van Elk, J; Winger, EE, 1994)
"Dinitrochlorobenzene (DNCB) is a contact sensitizing agent that acts as a potent immune modulator of dendritic cells."1.29Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection. ( Berger, TG; Dumlao, C; Elswood, BF; Epstein, WL; Kiprov, DD; Stricker, RB; Tappero, J; Van Elk, J; Zhu, YS, 1993)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's8 (88.89)18.2507
2000's1 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stricker, RB5
Goldberg, B2
Mills, LB1
Epstein, WL3
Elswood, BF3
Dumlao, C2
Van Elk, J2
Henry, J1
Winger, EE1
Zhu, YS1
Berger, TG1
Tappero, J1
Kiprov, DD1
Stone, OJ1
Smith, KJ1
Vidmar, D1
Skelton, HG1
Hackley, BE1
Traub, A1
Margulis, SB1
Spach, DH1
Colven, R1
De Lancie, R1

Trials

1 trial available for dinitrochlorobenzene and HIV Coinfection

ArticleYear
Topical immune modulation with dinitrochlorobenzene in HIV disease: a controlled trial from Brazil.
    Dermatology (Basel, Switzerland), 1997, Volume: 195, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adjuvants, Immunologic; Administration, Cutaneous; Adult; Anti-H

1997

Other Studies

8 other studies available for dinitrochlorobenzene and HIV Coinfection

ArticleYear
Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.
    Journal of the American Academy of Dermatology, 1995, Volume: 33, Issue:4

    Topics: Administration, Cutaneous; Adult; Antigens, Bacterial; Antigens, Fungal; CD4 Lymphocyte Count; CD4-P

1995
Clinical and immunologic evaluation of HIV-infected patients treated with dinitrochlorobenzene.
    Journal of the American Academy of Dermatology, 1994, Volume: 31, Issue:3 Pt 1

    Topics: Acquired Immunodeficiency Syndrome; Antigens, CD; CD4-CD8 Ratio; Dinitrochlorobenzene; Flow Cytometr

1994
Topical dinitrochlorobenzene in HIV disease.
    Journal of the American Academy of Dermatology, 1993, Volume: 28, Issue:5 Pt 1

    Topics: Administration, Cutaneous; Adult; CD4-Positive T-Lymphocytes; Dinitrochlorobenzene; HIV Infections;

1993
Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection.
    Immunology letters, 1993, Volume: 36, Issue:1

    Topics: Administration, Cutaneous; Administration, Topical; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; Dendr

1993
Inducing viral immunity without a vaccine--possible use with human immunodeficiency virus.
    Medical hypotheses, 1993, Volume: 40, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Dermatitis, Contact; Dermatitis, Toxicodendron; Dinitrochloroben

1993
Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.
    Journal of the American Academy of Dermatology, 1996, Volume: 35, Issue:3 Pt 1

    Topics: Catechols; CD8-Positive T-Lymphocytes; Cytokines; Dermatitis, Allergic Contact; Dinitrochlorobenzene

1996
Resolution of recalcitrant hand warts in an HIV-infected patient treated with potent antiretroviral therapy.
    Journal of the American Academy of Dermatology, 1999, Volume: 40, Issue:5 Pt 2

    Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Cryosurgery; Dinitr

1999
Hit harder than HAART.
    Lancet (London, England), 2000, Aug-26, Volume: 356, Issue:9231

    Topics: Dinitrochlorobenzene; HIV Infections; HIV-1; Humans; Irritants

2000